News | April 27, 2022
Syngene full-year revenue from operations up 19% to Rs. 2604 crore
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The investment will accelerate the overall Sarclisa development program
Subscribe To Our Newsletter & Stay Updated
